Vericel

Vericel is a biotech company in Ann Arbor, United States, founded in 1989. It has raised $40.0M across 1 round.

Advanced therapies for sports medicine and severe burn care

Employees
201–500
Founded
1989
Business Model
B2B
Total Funding
$40.0M
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Vericel Corporation is a publicly traded advanced cell therapy company (NASDAQ: VCEL) focused on the sports medicine and severe burn care markets in the United States. The company manufactures and markets MACI (autologous cultured chondrocytes on porcine collagen membrane) for repair of cartilage defects of the knee, Epicel (cultured epidermal autografts) for the treatment of severely burned patients, and holds an exclusive North American license for NexoBrid, a biological orphan product approved for eschar removal in severe thermal burns. Vericel is committed to improving the lives of patients with serious conditions through innovative cell therapies and specialty biologics, combining advances in cell biology with specialized manufacturing.

Summary

It lists 201–500 employees. It has raised $40.0M in total across 1 round. Investors include Silicon Valley Bank.

Funding History

Data from Indexed.vcUpdated
Debt FinancingDebt Facilities
$25.0M

Sign up to see all 2 events

Funding, valuations, and company events, with amounts and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vericel on Indexed.vc
<a href="https://indexed.vc/companies/vericel"><img src="https://indexed.vc/api/badge/company/vericel" alt="Vericel on Indexed.vc" width="260" height="76" /></a>